Spruce Biosciences, Inc
NASDAQ:SPRB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Spruce Biosciences, Inc (SPRB) under the Base Case is USD per share.
Compared with the current market price of 38 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Our estimate of what one share is worth.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Spruce Biosciences Does
Spruce Biosciences is a development-stage biotechnology company that works on medicines for rare endocrine disorders, especially conditions tied to abnormal hormone production. Its main drug candidate has been tildacerfont, an oral medicine designed to treat congenital adrenal hyperplasia, a lifelong genetic disease that can cause the body to make too many stress hormones.
- Headquarters
- United States of America US
- Employees
- 9
- IPO date
- Oct 9, 2020
Balance Sheet
Continue SPRB Research
Decided on Spruce Biosciences? Get an email when SPRB reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one SPRB stock?
The intrinsic value for
Spruce Biosciences, Inc (SPRB) under the Base Case is USD.
Is SPRB stock undervalued or overvalued?
Compared with the current market price of 38 USD, the stock appears .